XML 46 R35.htm IDEA: XBRL DOCUMENT v3.8.0.1
Supplemental Financial Information (Tables)
9 Months Ended
Sep. 30, 2017
Balance Sheet Related Disclosures [Abstract]  
Accounts Receivables
Accounts receivable, net, consisted of the following (in thousands):
 
 
September 30, 2017
 
December 31, 2016
Trade receivables from third parties
 
$
326,498

 
$
285,336

Allowance for bad debt
 
(12,457
)
 
(9,606
)
 
 
$
314,041

 
$
275,730

Inventories
Inventories consisted of the following (in thousands):

 
September 30, 2017
 
December 31, 2016
Raw materials
 
$
51,628

 
$
47,704

Work-in-process
 
39,873

 
32,316

Finished goods
 
123,092

 
103,469

 
 
$
214,593

 
$
183,489

Prepaid Expenses and Other Current Assets
Prepaid expenses and other current assets consisted of the following (in thousands):
 
 
September 30, 2017
 
December 31, 2016
Income taxes payable on inter-company transfers of property (1)
 
$
19,445

 
$
19,445

Deposits and advances to suppliers
 
7,298

 
5,417

Earthquake grant receivable
 
4,983

 
4,748

Unbilled receivables
 
4,363

 

Escrow deposit - Caisson
 
2,000

 

Current loans and notes receivable
 
1,553

 
7,093

Derivative contract assets
 

 
8,269

Other prepaid expenses
 
15,534

 
11,001

 
 
$
55,176

 
$
55,973

(1)
The income taxes payable on intercompany transfers of property asset is the asset account created to defer the income tax effect of an intercompany intellectual property sale pursuant to ASC 810-10-45-8.
Other Long-term Assets
Other assets consisted of the following (in thousands):
 
 
September 30, 2017
 
December 31, 2016
Income taxes payable on inter-company transfers of property (1)
 
$
109,971

 
$
124,551

Investments (2)
 
2,316

 
2,537

Loans and notes receivable
 
1,964

 
2,029

Escrow deposit - Caisson
 
1,000

 

Guaranteed deposits
 
777

 
940

Other
 
1,827

 
641

 
 
$
117,855

 
$
130,698

(1)
The income taxes payable on intercompany transfers of property asset is the asset account created to defer the income tax effect of an intercompany intellectual property sale pursuant to ASC 810-10-45-8.
(2)
Primarily cash surrender value of company owned life insurance policies.
Accrued Liabilities
Accrued liabilities and other consisted of the following (in thousands):
 
 
September 30, 2017
 
December 31, 2016
Product remediation liability (1)
 
$
20,060

 
$
23,464

Deferred compensation - Caisson acquisition
 
14,137

 

Legal and other administrative costs
 
7,863

 
6,184

Provisions for agents, returns and other
 
8,505

 
7,271

Restructuring related liabilities
 
5,098

 
16,859

Product warranty obligations
 
1,747

 
2,736

Royalty costs
 
2,048

 
2,503

Escrow indemnity liability - Caisson
 
2,000

 

Deferred income
 
4,752

 

Government grants
 
1,275

 
1,708

Derivative contract liabilities (2)
 
3,055

 
942

Research and development costs
 
1,173

 
839

Other
 
20,499

 
13,061

 
 
$
92,212

 
$
75,567


(1)
Refer to “Note 4. Product Remediation Liability.”
(2)
Refer to “Note 8. Derivatives and Risk Management.”
Other Long-term Liabilities
Other long-term liabilities consisted of the following (in thousands):

 
September 30, 2017
 
December 31, 2016
Contingent consideration (1)
 
$
34,217

 
$
3,890

Uncertain tax positions
 
12,349

 
11,108

Product remediation liability (2)
 
10,186

 
10,023

Government grants
 
5,889

 
3,803

Derivative contract liabilities (3)
 
932

 
1,392

Escrow indemnity liability - Caisson
 
1,000

 

Unfavorable operating leases (4)
 
256

 
1,672

Other
 
9,575

 
7,599

 
 
$
74,404

 
$
39,487

(1)
The contingent consideration liability represents contingent payments related to three acquisitions: the first and second acquisitions, in September 2015, were Cellplex PTY Ltd. in Australia and the commercial activities of a local distributor in Colombia. The contingent payments for the first acquisition are based on achievement of sales targets by the acquiree through June 30, 2018 and the contingent payments for the second acquisition are based on sales of cardiopulmonary disposable products and heart lung machines of the acquiree through December 2019. Refer to “Note 6. Fair Value Measurements.” The third acquisition, Caisson, occurred in May 2017. Refer to “Note 2. Acquisitions.”
(2)
Refer to “Note 4. Product Remediation Liability.”
(3)
Refer to “Note 8. Derivatives and Risk Management.”
(4)
Unfavorable operating leases represent the adjustment to recognize future lease obligations at their estimated fair value in conjunction with the Mergers.